The concurrent chemoradiotherapy was performed for the patients of postoperative head and neck cancer. A dose of 40 Gy was delivered to the subclinical region, and an additional dose of 20-30 Gy to the high-risk or recurrent region. No local or regional relapses were found in our follow-up period.
|Number of pages||4|
|Journal||Japanese Journal of Clinical Radiology|
|Publication status||Published - 2013 Mar 1|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging